Rubanyi GM - Search Results

1

Angiogenic gene therapy for refractory angina.

Rubanyi GM. Rubanyi GM. Expert Opin Biol Ther. 2016;16(3):303-15. doi: 10.1517/14712598.2016.1122753. Epub 2015 Dec 14. Expert Opin Biol Ther. 2016. PMID: 26581236 Review.

2

Identifying and overcoming obstacles in angiogenic gene therapy for myocardial ischemia.

Rubanyi GM. Rubanyi GM. J Cardiovasc Pharmacol. 2014 Aug;64(2):109-19. doi: 10.1097/FJC.0000000000000107. J Cardiovasc Pharmacol. 2014. PMID: 24736636 Review.

3

Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.

Rubanyi GM. Rubanyi GM. Mol Ther. 2013 Apr;21(4):725-38. doi: 10.1038/mt.2013.13. Epub 2013 Feb 12. Mol Ther. 2013. PMID: 23403495 Free PMC article. Review.

4

Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.

Qian HS, Liu P, Huw LY, Orme A, Halks-Miller M, Hill SM, Jin F, Kretschmer P, Blasko E, Cashion L, Szymanski P, Vergona R, Harkins R, Yu J, Sessa WC, Dole WP, Rubanyi GM, Kauser K. Qian HS, et al. Among authors: rubanyi gm. Gene Ther. 2006 Sep;13(18):1342-50. doi: 10.1038/sj.gt.3302781. Epub 2006 Apr 27. Gene Ther. 2006. PMID: 16642030

5

The future of human gene therapy.

Rubanyi GM. Rubanyi GM. Mol Aspects Med. 2001 Jun;22(3):113-42. doi: 10.1016/s0098-2997(01)00004-8. Mol Aspects Med. 2001. PMID: 11470139 Review.

6

Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor 4: report of preclinical data.

Gao MH, Lai NC, McKirnan MD, Roth DA, Rubanyi GM, Dalton N, Roth DM, Hammond HK. Gao MH, et al. Among authors: rubanyi gm. Hum Gene Ther. 2004 Jun;15(6):574-87. doi: 10.1089/104303404323142024. Hum Gene Ther. 2004. PMID: 15212716

7

Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease.

Grines C, Rubanyi GM, Kleiman NS, Marrott P, Watkins MW. Grines C, et al. Among authors: rubanyi gm. Am J Cardiol. 2003 Nov 7;92(9B):24N-31N. doi: 10.1016/s0002-9149(03)00965-2. Am J Cardiol. 2003. PMID: 14615023 Review.

8

Effect of estrogen on endothelial function and angiogenesis.

Rubanyi GM, Johns A, Kauser K. Rubanyi GM, et al. Vascul Pharmacol. 2002 Feb;38(2):89-98. doi: 10.1016/s0306-3623(02)00131-3. Vascul Pharmacol. 2002. PMID: 12379955 Review.

9

Age-dependent acceleration of ischemic injury in endothelial nitric oxide synthase-deficient mice: potential role of impaired VEGF receptor 2 expression.

Qian HS, de Resende MM, Beausejour C, Huw LY, Liu P, Rubanyi GM, Kauser K. Qian HS, et al. Among authors: rubanyi gm. J Cardiovasc Pharmacol. 2006 Apr;47(4):587-93. doi: 10.1097/01.fjc.0000211736.55583.5c. J Cardiovasc Pharmacol. 2006. PMID: 16680073

10

Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen.

Kauser K, Rubanyi GM. Kauser K, et al. Among authors: rubanyi gm. J Vasc Res. 1997 May-Jun;34(3):229-36. doi: 10.1159/000159227. J Vasc Res. 1997. PMID: 9226305 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page